3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Transitional Cell
16
Urinary Bladder Neoplasms
15
Carcinoma, Merkel Cell
10
Neoplasm Metastasis
8
Carcinoma, Renal Cell
8
Breast Neoplasms
8
Neoplasms
6
Triple Negative Breast Neoplasms
5
Melanoma
5
Ureteral Neoplasms
4
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Ovarian Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urethral Neoplasms
3
Skin Neoplasms
3
Prostatic Neoplasms
3
Colorectal Neoplasms
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Neuroendocrine Tumors
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Hepatocellular
2
Uveal Melanoma
1
Urothelial Cancer
1
Turcot syndrome
1
Thymoma
1
Interventions
Injections
20
Carboplatin
9
pembrolizumab
8
Bevacizumab
6
Pemetrexed
5
Paclitaxel
5
Leucovorin
5
Fluorouracil
5
fludarabine
4
Oxaliplatin
4
Docetaxel
4
sotorasib
3
atezolizumab
3
Drug Therapy
3
Cyclophosphamide
3
Capecitabine
3
trifluridine tipiracil drug combination
2
trametinib
2
toripalimab
2
spartalizumab
2
palbociclib
2
olaparib
2
Panitumumab
2
Immune Checkpoint Inhibitors
2
Fulvestrant
2
Etoposide
2
Cisplatin
2
Cetuximab
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumors
×
avelumab
×
1 year
×
Clear all
No trials found.